Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Philosys new Gmate SMART blood glucose monitor wins CE mark

Philosys, a contract design, development and manufacturing company, has obtained CE mark approval for its new Gmate SMART blood glucose monitor.

By using the operating system of the smart phone, the patent pending technology of the Gmate SMART works with the iPhone, iPad and iPod devices by plugging the device into the headphone connector of the smart phone.

Regulatory Affairs director Jonathan Johnson said CE designation will allow Philosys to market the Gmate SMART within the European Union consisting of the 27 EU member states.

"Moreover, the CE mark signifies that the product has been assessed before being placed on the market and meets European Union safety, health and environmental protection requirements," Johnson added.

Philosys operations manager Jennifer Kupar said with the launch of the Gmate SMART in Europe, the company provides the perfect solution to diabetics looking for new technology to help monitor blood glucose levels in an active, fast paced lifestyle.

"As smart phone usage continues to increase in Europe, there is a growing demand for this breakthrough patent-pending technology that Philosys can deliver," Kupar added.